Review Article 


Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach

Pranav Bhagwat, Pravin M Bhat, Sunil Kewat.

Abstract
The COVID-19 outbreak changed the scenario in medical fraternity by challenging in many ways. The viral pneumonia due to SARS-CoV-2 became fatal in comorbidities like uncontrolled diabetes mellitus, chronic pulmonary diseases, and immunocompromised status of the patient. The factors like use of corticosteroids in uncontrolled diabetes patients with COVID-19, use of immunomodulators like Tocilizumab, Itolizumab, mechanical ventilation and a long-standing oxygen therapy are responsible for secondary opportunistic fungal infections like mucormycosis. The fulminant opportunistic fungal mucormycosis has a high mortality rate even with treatment. The mucormycosis manifested in many ways as rhino-orbito-cerebral mucormycosis, pulmonary, gastrointestinal, cutaneous, etc. The rhino-orbito-cerebral mucormycosis has a high incidence rate among all type and is fatal leading to death due to invasion in cerebral area. The treatment options are very limited like surgical debridement of the mucor and use of intravenous Liposomal Amphotericin B, Posaconazole which raise financial burden on already COVID affected patient. There is an urgency to find out possible solution from Ayurveda. Ayurveda classics explained about the principles of Shuddha Chikitsa (~non adulterated therapy) through which patient will not develop an iatrogenic disease. The mucormycosis is a Vyadhisankar (~ cluster of two or more diseases) of COVID-19 (~Sannipatik Jwar) and Visha. Various other aspects like Agantuja Vyadhi (~exogenous disease), Visarpa (~herpes) and Nidanarthakar Vyadhi (~ a disease itself become causative factor for other diseases) can also be considered while treating mucormycosis as per Ayurveda. The treatment principles of mucormycosis can be divided into preventive and curative measures with Ayurveda medicines. Due to the complexity of disease various aspect of the disease are discussed with possible treatment protocol for mucormycosis as a post COVID complication.

Key words: COVID-19, Mucormycosis, Shuddha Chikitsa, Visha, corticosteroids, Vyadhisankar


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pranav Bhagwat
Articles by Pravin M Bhat
Articles by Sunil Kewat
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Bhagwat P, Bhat PM, Kewat S. Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach. AAM. 2022; 11(1): 64-72. doi:10.5455/AAM.106410


Web Style

Bhagwat P, Bhat PM, Kewat S. Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach. https://www.aamjournal.in/?mno=106410 [Access: July 16, 2022]. doi:10.5455/AAM.106410


AMA (American Medical Association) Style

Bhagwat P, Bhat PM, Kewat S. Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach. AAM. 2022; 11(1): 64-72. doi:10.5455/AAM.106410



Vancouver/ICMJE Style

Bhagwat P, Bhat PM, Kewat S. Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach. AAM. (2022), [cited July 16, 2022]; 11(1): 64-72. doi:10.5455/AAM.106410



Harvard Style

Bhagwat, P., Bhat, . P. M. & Kewat, . S. (2022) Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach. AAM, 11 (1), 64-72. doi:10.5455/AAM.106410



Turabian Style

Bhagwat, Pranav, Pravin M Bhat, and Sunil Kewat. 2022. Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach. Annals of Ayurvedic Medicine, 11 (1), 64-72. doi:10.5455/AAM.106410



Chicago Style

Bhagwat, Pranav, Pravin M Bhat, and Sunil Kewat. "Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach." Annals of Ayurvedic Medicine 11 (2022), 64-72. doi:10.5455/AAM.106410



MLA (The Modern Language Association) Style

Bhagwat, Pranav, Pravin M Bhat, and Sunil Kewat. "Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach." Annals of Ayurvedic Medicine 11.1 (2022), 64-72. Print. doi:10.5455/AAM.106410



APA (American Psychological Association) Style

Bhagwat, P., Bhat, . P. M. & Kewat, . S. (2022) Mucormycosis- A Post COVID-19 Challenge and Ayurvedic Approach. Annals of Ayurvedic Medicine, 11 (1), 64-72. doi:10.5455/AAM.106410




Current Issue : 2022, Vol: 11, Issue: 3
E-ISSN : 2347-6923
ISSN : 2277-4092
ISSUES : 4 per year
PUBLISHER : Association of Ayurvedic Physicians of India

Benefits of publishing in Annals of Ayurvedic Medicine

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review

Abstracting and Indexing Information

DOAJ

Google Scholar,

DHARA (http://www.dharaonline.org)

Ayush Research Portal (http://ayushportal.nic.in/)

Member of 

COPE ( Committee on Publication Ethics)

ICoAJE - International Committee of Ayurveda Journal Editors

Listed In

UGC-CARE list of Journals (2019)

List of Journals stating that they follow the ICMJE Recommendations ( 2017) 

.................................................................

AAM confirms its adherence with guidelines and best practices published by professional organizations, including Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf) from ICMJE and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; (http://doaj.org/bestpractice).

.................................................................................................

The articles in Annals of Ayurvedic Medicine are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial  Share Alike License (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited and distributed with the same licence as the original .

An Official Journal of 


 IASTAM member logo


Benefit Programs | SSP Society for Scholarly Publishing
 
Articles published in AAM are now being given Plum X Metrics depending upon the social media attention the articles have received. The Plum Print next to each article shows the relative activity in the categories of metrics: Captures, Mentions, Social Media and Citations. Click on the abstract of the article to see social media related attention the article has recieved .
 
Indexed by PlumX Metrics as a blog source for published research ...